Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Irinotecan × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 8 Neoplasm Metastasis 6 Sarcoma, Ewing 5 Pancreatic Neoplasms 5 Rhabdomyosarcoma 4 Colonic Neoplasms 4 Sarcoma 3 Rectal Neoplasms 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2 Recurrence 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neuroblastoma 2 Neoplasms 2 Medulloblastoma 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Ependymoma 2 Endometrial Neoplasms 2 Colorectal Adenocarcinoma 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdoid Tumor 1

Interventions

pembrolizumab 26 Cisplatin 21 Cetuximab 19 Carboplatin 18 Magnetic Resonance Spectroscopy 12 Specimen Handling 11 Radiotherapy, Intensity-Modulated 11 Paclitaxel 8 Radiotherapy 7 Platinum 7 Nivolumab 7 Fluorouracil 7 Docetaxel 7 1,2-diaminocyclohexaneplatinum II citrate 7 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 5 Ipilimumab 4 atezolizumab 3 Taxes 3 Radiosurgery 3 Immunoglobulin G 3 Fulvestrant 3 Drug Therapy 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 dehydroftorafur 2 cemiplimab 2 Surgical Procedures, Operative 2 Radiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡